Click Therapeutics, Inc
Click Therapeutics - Model CT-161 - Overactive Bladder
CT-161 is under development as a clinically-validated digital program for overactive bladder.
Most popular related searches
overactive bladder
class II medical device
clinical validation
urinary urgency
patient engagement
medical device
urinary frequency
clinical program
medication adherence
medical adherence
- Behavior Modification
- Diet Optimization
- Guided Physical Exercise
- Controlled Breathing
- Personalized Messaging
- Medication Access & Adherence
CT-161 combines multiple clinically-validated mechanisms of action with Click’s adaptive patient engagement platform and is designed to reduce urinary urgency and frequency in patients with overactive bladder. Click is seeking FDA clearance for CT-161 as a Class II medical device for the treatment of overactive bladder.